Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,710 total articles

FTI Consulting CFO Nam's Stock Acquisition Amid Market Dip

FTI Consulting CFO Nam's Stock Acquisition Amid Market Dip

Eun Nam, Chief Financial Officer of FTI Consulting, Inc., recently acquired shares of the company's common stock. This insider transaction occurred while the stock was trading near its 52-week low. Despite an earnings per share (EPS) figure that fell short of expectations in Q1 2026, the firm exceeded revenue forecasts and announced several strateg…

FTI Consulting Officer Buys Shares Amid Stock Dip; Company Reports Mixed Q1 Performance and Key Leadership Appointments

FTI Consulting Officer Buys Shares Amid Stock Dip; Company Reports Mixed Q1 Performance and Key Leadership Appointments

Linton Paul Alderman, Chief Strategy/Transformation Officer at FTI Consulting (NYSE:FCN), recently purchased shares of the company's common stock. This transaction occurred when the stock was trading near its 52-week minimum. Separately, FTI Consulting reported Q1 2026 earnings that provided a mixed picture, with revenue surpassing estimates but ea…

Director's Buy at ADMA Biologics Amid Valuation Questions

Director's Buy at ADMA Biologics Amid Valuation Questions

ADMA Biologics director Jerrold B. Grossman conducted an open market purchase of company stock on May 12, 2026. This transaction occurred while the common stock was trading near its 52-week low and after the company reported Q1 financial results that failed to meet market expectations. The report details his direct holdings, indirect ownership stru…

Insider Selling at Clover Health Amid Mixed Q1 Results

Insider Selling at Clover Health Amid Mixed Q1 Results

Clover Health Investments Corp. (CLOV) saw its CEO sell a substantial block of company stock in May 2026. This insider activity occurred alongside the release of Q1 2026 earnings results, where the company reported revenue exceeding expectations but missed analyst forecasts for earnings per share. The mixed financial performance provides context to…

Mineralys CMO Activity and Company Developments Offer Mixed Signals

Mineralys CMO Activity and Company Developments Offer Mixed Signals

The Chief Medical Officer of Mineralys Therapeutics, Inc., Dr. David Malcom Rodman, recently executed a series of transactions involving the company's common stock. These sales generated substantial proceeds, while simultaneous option exercises resulted in new holdings. Despite these insider movements, which were conducted under a pre-arranged trad…

Director Moore Executes Stock Transactions at Texas Roadhouse; Recent Earnings and Analyst Actions Provide Context

Director Moore Executes Stock Transactions at Texas Roadhouse; Recent Earnings and Analyst Actions Provide Context

Texas Roadhouse director Gregory N. Moore conducted multiple stock transactions on May 11, 2026, including a significant sale through the Moore Family Trust and a gift to a charitable foundation. This activity was reported alongside Texas Roadhouse's mixed Q1 2026 earnings results and subsequent analyst actions. While the company surpassed EPS expe…

Aura Minerals CEO's Stock Sales and Q1 Results Under Scrutiny

Aura Minerals CEO's Stock Sales and Q1 Results Under Scrutiny

Rodrigo Cardoso Barbosa, the President and CEO of Aura Minerals Inc. (NASDAQ:AUGO), recently executed significant common share sales totaling approximately $9.43 million over two days in May 2026. These insider transactions occurred alongside the release of the company's first-quarter 2026 earnings, which revealed performance below market expectati…

Insider Activity and Quarterly Results for Exponent Inc.

Insider Activity and Quarterly Results for Exponent Inc.

Joseph Sala, a Group Vice President at Exponent Inc., executed an insider sale of company stock. This transaction occurred against the backdrop of recent market movement for Exponent (NASDAQ:EXPO), which has declined recently. Despite this dip, the company reported first-quarter 2026 earnings that surpassed analyst expectations, indicating strong f…

Executive Transactions and Quarterly Updates at MannKind Corp Offer Insight into Company Valuation

Executive Transactions and Quarterly Updates at MannKind Corp Offer Insight into Company Valuation

MannKind Corp's Executive Vice President, General Counsel & Secretary, David Thomson, executed multiple transactions involving the sale and disposal of company common stock. These movements occurred amid broader corporate developments, including the release of first-quarter 2026 financial results. The quarter showed a notable year-over-year revenue…